Type 2 Diabetes
New Pooled Analysis Found Lantus(R) Reduced A1C and FBG Levels in Adults Over 65 with Type 2 Diabetes Compared to Those Treated with NPH
Published in Law and Health Weekly, June 27th, 2009
Sanofi-aventis U.S. presented results of a new study, "Safety and Efficacy of Insulin Glargine Compared With NPH Insulin in Older Adults With Type 2 Diabetes: Results from a Pooled Analysis," that examined the safety and efficacy of Lantus(R) (insulin glargine [rDNA origin] injection) compared to insulin NPH in older adults with type 2 diabetes. The study, presented as a poster during the 69th Annual Scientific Sessions of the American Diabetes Association (ADA), found that among patients 65 or younger, there was no significant difference between Lantus(R) and NPH in A1C reduction (1.26% for Lantus(R), 1.20% for NPH) or fasting blood glucose (FBG) reduction (86 mg/dL for Lantus(R), 84...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives Extension for Nasdaq Listing Compliance - ABI Research
Despite Bankruptcy, General Motors Tops New ABI Research Global OEM Telematics Vendor Matrix Ranking - Acacia Research Corporation
Acacia Research to Present at UBS Global Technology and Services Conference - Advocate Capital, Inc.
Advocate Capital, Inc. Celebrates Its 10th Anniversary - AIDS Healthcare Foundation
The Deadbeat State: California Sued for Not Paying Savings to State’s Largest AIDS Group - America's Agenda
Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
